Terkko Navigator / The Journal of infectious diseases

The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro–Cortistatin A

Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure

The Search for an HIV Cure: Where Do We Go From Here?

Challenges and Promise of Human Immunodeficiency Virus Remission

Antibodies for Human Immunodeficiency Virus-1 Cure Strategies

The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts

Challenges and Opportunities of Using Adoptive T-Cell Therapy as Part of an HIV Cure Strategy

Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates

Erratum to: Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults≥50 Years of Age

Molecular Epidemiology of Mansonella Species in Gabon

High Prevalence of Mansonella Species and Parasitic Coinfections in Gabon Calls for an End to the Neglect of Mansonella Research

Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial

Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody Responses

Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes

Rapid, Sensitive, and Specific Severe Acute Respiratory Syndrome Coronavirus 2 Detection: A Multicenter Comparison Between Standard Quantitative Reverse-Transcriptase Polymerase Chain Reaction and CRISPR-Based DETECTR

Erratum to: Kinetics of Hepatitis B Core–Related Antigen and Anti–Hepatitis B Core Antibody and Their Association With Serological Response in Human Immunodeficiency Virus–Hepatitis B Coinfection

Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Corrigendum to: Transcriptome Assessment of Erythema Migrans Skin Lesions in Patients With Early Lyme Disease Reveals Predominant Interferon Signaling

Associations of Cytomegalovirus Infection With All-Cause and Cardiovascular Mortality in Multiple Observational Cohort Studies of Older Adults

Cytomegalovirus and Your Health: Not a Matter of the Heart, Nor of Life and Death

Measuring the Haystack’s Needles

Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy

Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With Ciprofloxacin

Predicting Vibrio cholerae Infection and Disease Severity Using Metagenomics in a Prospective Cohort Study

Presence of Antibodies Against Haemophilus influenzae Serotype a in Alaska Before and After the Emergence of Invasive Infections

Steep Rebound of Chloroquine-Sensitive Plasmodium falciparum in Zimbabwe

Association of Genetic Polymorphisms in DC-SIGN, Toll-Like Receptor 3, and Tumor Necrosis Factorα Genes and the Lewis-Negative Phenotype With Chikungunya Infection and Disease in Nicaragua

Macrophage Depletion in CCR2−/− Mice Delays Bacterial Clearance and Enhances Neutrophil Infiltration in an Acute Otitis Media Model

A Phase 1, Open-Label Assessment of a Dengue Virus-1 Live Virus Human Challenge Strain

Characterization of the Type-Specific and Cross-Reactive B-Cell Responses Elicited by a Live-Attenuated Tetravalent Dengue Vaccine

Detection of Respiratory Syncytial Virus or Rhinovirus Weeks After Hospitalization for Bronchiolitis and the Risk of Recurrent Wheezing

IL-10 and Its Related Superfamily Members IL-19 and IL-24 Provide Parallel/Redundant Immune-Modulation in Loa loa Infection

Challenges of Discrepant HIV Tests in Pregnant Women in the PrEP era—to Treat or Not to Treat?

Expression Pattern of the Pneumocystis jirovecii Major Surface Glycoprotein Superfamily in Patients with Pneumonia

Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure?

Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic

Hepatitis C Virus in Pregnancy: Are We Ready for Test and Treat?

30 Years on the Road to Hepatitis C Elimination

Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection: Fulfilling the Potential on the Road to Elimination

Hepatitis C Virus Treatment: Simplifying the Simple and Optimizing the Difficult

We Must Do Better: Addressing HCV Treatment Barriers in Persons Who Inject Drugs in the United States

Hepatitis C Virus Treatment as Prevention: Challenges and Opportunities in Men Who Have Sex With Men

Direct-Acting Antivirals and Organ Transplantation: Is There Anything We Can’t Do?

Reviewers Vol 2 2020

Immunosenescence and Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development

Location Matters: Geographic Disparities and Impact of Coronavirus Disease 2019

No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic

A Granulocytic Signature Identifies COVID-19 and Its Severity

SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors

High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts